SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
TAMBAKERAS MARKOS I

(Last) (First) (Middle)
1133 WESTCHESTER AVENUE
C/O XYLEM INC.

(Street)
WHITE PLAINS NY 10604

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/01/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $19.4 11/01/2011 A 3,560 (1) 05/07/2012 Common Stock 3,560 $0.00 3,560 D
Stock Option (Right to Buy) $17.35 11/01/2011 A 2,420 (1) 01/04/2013 Common Stock 2,420 $0.00 2,420 D
Stock Option (Right to Buy) $21.03 11/01/2011 A 2,480 (1) 02/02/2014 Common Stock 2,480 $0.00 2,480 D
Stock Option (Right to Buy) $25.53 11/01/2011 A 2,140 (1) 03/08/2012 Common Stock 2,140 $0.00 2,140 D
Stock Option (Right to Buy) $29.57 11/01/2011 A 3,040 (1) 03/06/2013 Common Stock 3,040 $0.00 3,040 D
Stock Option (Right to Buy) $32.56 11/01/2011 A 2,700 (1) 03/07/2014 Common Stock 2,700 $0.00 2,700 D
Stock Option (Right to Buy) $29.81 11/01/2011 A 2,960 (1) 03/10/2015 Common Stock 2,960 $0.00 2,960 D
Stock Option (Right to Buy) $18.63 11/01/2011 A 3,970 (2) 03/05/2016 Common Stock 3,970 $0.00 3,970 D
Stock Option (Right to Buy) $30.03 11/01/2011 A 2,860 (3) 03/05/2020 Common Stock 2,860 $0.00 2,860 D
Explanation of Responses:
1. These options are fully vested and exercisable.
2. 2,647 options are vested and exercisable and the remainder will vest on March 5, 2012.
3. 954 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.
Remarks:
Securities reported herein as having been acquired were equity awards formerly granted by ITT Corporation converted into equity awards of Xylem Inc. in connection with the spin-off of Xylem Inc. from ITT Corporation.
/s/ Rina E. Teran, Assistant Corporate Secretary of Xylem Inc., by power of attorney for Markos I. Tambakeras 11/03/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY



	The undersigned, Markos I. Tambakeras, does hereby nominate, constitute and
appoint Frank R. Jimenez and Rina E. Teran in their true and lawful attorney and
agent to do any and all acts and things and execute and file any and all
instruments which said attorneys and agents may deem necessary or advisable to
enable the undersigned (in his individual capacity or in any other capacity) to
comply with the Securities Exchange Act of 1934 (the "34 Act") and the
Securities Act of 1933 (the "33 Act") and any requirements of the Securities and
Exchange Commission (the "SEC") in respect thereof, in connection with the
preparation, execution and/or filing of (i) any report or statement of
beneficial ownership or changes in beneficial ownership of securities of Xylem
Inc., an Indiana corporation (the "Company"), that the undersigned (in his
individual capacity or in any other capacity) may be required to file pursuant
to Section 16(a) of the 34 Act, including any report or statement on Form 3,
Form 4 or Form 5, or to any amendment thereto, (ii) any report or notice
required under Rule 144 of the 33 Act, including Form 144, or any amendment
thereto, and (iii) any and all other documents or instruments that may be
necessary or desirable in connection with or in furtherance of any of the
foregoing, including Form ID, or any amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the undersigned
to make electronic filings with the SEC of reports required pursuant to Section
16(a) of the 34 Act or any rule or regulation of the SEC, such power and
authority to extend to any form or forms adopted by the SEC in lieu of or in
addition to any of the foregoing and to include full power and authority to sign
the undersigned's name in his individual capacity or otherwise, hereby ratifying
and confirming all that said attorneys and agents, or any of them, shall do or
cause to be done by virtue thereof.

	This authorization shall supersede all prior authorizations to act for the
undersigned with respect to securities of the Company in such matters, which
prior authorizations are hereby revoked, and shall remain in effect until
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys in fact.

	IN WITNESS WHEREOF, I have hereunto set my hand this 4th day of October, 2011.



/s/
Markos I. Tambakeras